High CRP Levels Predict Risk of Eye Disease (CME/CE)
(MedPage Today) -- High levels of the proinflammatory marker C-reactive protein predicted an increased risk of age-related macular degeneration, including neovascular AMD, data from five large studies showed. (Source: MedPage Today Ophthalmology)
Source: MedPage Today Ophthalmology - February 8, 2013 Category: Opthalmology Source Type: news
Little Help from Lucentis for Vitreous Hemorrhage (CME/CE)
(MedPage Today) -- Patients with vitreous hemorrhage related to diabetic retinopathy derived minimal short-term benefit from treatment with the angiogenesis inhibitor ranibizumab (Lucentis), results of a randomized trial showed. (Source: MedPage Today Ophthalmology)
Source: MedPage Today Ophthalmology - February 5, 2013 Category: Opthalmology Source Type: news
Little Help from Lucentis for Diabetic Eyes (CME/CE)
(MedPage Today) -- Patients with vitreous hemorrhage related to diabetic retinopathy derived minimal short-term benefit from treatment with the angiogenesis inhibitor ranibizumab (Lucentis), results of a randomized trial showed. (Source: MedPage Today Ophthalmology)
Source: MedPage Today Ophthalmology - February 1, 2013 Category: Opthalmology Source Type: news
Microvascular Changes Might Predict Glaucoma (CME/CE)
(MedPage Today) -- Changes in blood vessels in the eye might be an early warning sign of glaucoma, researchers reported. (Source: MedPage Today Ophthalmology)
Source: MedPage Today Ophthalmology - January 4, 2013 Category: Opthalmology Source Type: news
